Atlas Trials

Study To Evaluate The Efficacy And Safety Of Balovaptan In Adults With Post-Traumatic Stress Disorder (PTSD)

Clinical trial NCT05401565 · COMPLETED

Trial details

NCT number
NCT05401565
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Stress Disorders, Post-Traumatic
Start date
2022-08-02
Primary completion
2023-10-05
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.